Advertisement
YOU ARE HERE: LAT HomeCollections

BRIEFLY

Pharmaceuticals

November 11, 2000

* BASF, Europe's biggest chemical manufacturer, is considering bids of at least $6 billion for its Knoll drug unit, people familiar with the situation said. Analysts said bidders, which could include Bristol-Myers Squibb Co. and Eli Lilly & Co., are said to attracted to Knoll's rheumatoid arthritis drug D2E7.

Advertisement
Los Angeles Times Articles
|
|
|